Thursday 30 May 2013

NICE backs Astra, Bristol diabetes drug in some cases

LONDON (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new diabetes drug from Bristol-Myers Squibb and AstraZeneca in some circumstances, marking a change of tack following an earlier blanket rejection. The National Insti...

Source: http://health.yahoo.net/news/s/nm/nice-backs-astra-bristol-diabetes-drug-in-some-cases

for more more information more info info

No comments:

Post a Comment

Note: only a member of this blog may post a comment.